Stock Recommendation Tracker
The Stock Recommendation Tracker is a table that features all of the current recommendations in all of our portfolios. It’s a quick way for you to see what stocks are currently in our portfolios and will highlight new additions or any changes to our recommendations over the previous week. We include this table at the bottom of the Weekly Summary, and provide a link here at the top to the Stock Recommendations Tracker.
Cabot Weekly Review (Video)
In this week’s stock market video, Mike Cintolo talks about the market’s interesting week, with some noteworthy early-week breadth on the upside and more than a few stocks that perked up. Of course, two days isn’t enough to change the trends, so Mike remains heavily in cash, is keeping any positions small and is building a watch list of resilient names for when the bulls show up for good. Stocks included in this video: LVS ASO NBIX LPLA CHRD FANG DKS ISEE.
UPCOMING CABOT EVENTS:
Cabot Prime Insider Live Analyst Briefing with Q&A: 4th Quarter 2022
FREE WEBINAR: October 19, 2022 Sign up now.
How to Generate Inflation-Beating Yield Using Crypto
FREE WEBINAR: October 20, 2022 Sign up now.
Cabot Growth Investor
Bi-weekly Issue October 6: From a top-down perspective, there are some rays of light out there–some of this week’s up volume has been very rare, and it comes on the heels of an onslaught of pessimism. That said, none of our indicators have flashed green, and the biggest thing we’re still seeing is selling on strength–this week, Enphase cracked and forced us to sell. We are adding two half-sized positions tonight in stocks from our watch list, but we’re remaining defensive with 78% in cash.
Alert October 5: The market has a solid start to the week, and there were some intriguing breadth measures during the pop. But our market timing indicators are still clearly negative, and more important, we’re actually seeing growth stocks either not participate much on the upside—or start to crack on today’s selling. This bulletin concerns Enphase (ENPH), which has been a port in the storm but is decisively breaking down today; we’re cutting bait here and holding the cash.
Bi-weekly Update September 29: Remain cautious. There’s not much new to say about the market—it’s weak, the trend is clearly down and more resilient stocks are beginning to get hit. Panic is clearly setting in, so our antennae are up for any sort of turn higher, but as always, we have to see it first before acting on it. We sold our stake in Devon Energy (DVN) on a special bulletin earlier this week, leaving us with just two stocks and a cash hoard of 79%. Details below.
Cabot Top Ten Trader
Movers & Shakers October 7: Overall, it’s been an interesting week: The major indexes have bounced nicely even including a morning selloff on the jobs report, up in the 3% range, and early this week we did see some unusual upside breadth—Tuesday’s NYSE up volume outpaced down volume by 20- to 25-to-1 (depending on exactly how you measure it), which, when coming after a selling deluge, has frequently marked low points.
Weekly Issue October 3: This week’s list has another crop of resilient stocks from a variety of different areas, from medical to energy to restaurants. Our Top Pick is a familiar growth stock that went through the wringer and is now base-building normally despite the market’s grumpiness.
Cabot Options Trader and Cabot Options Trader Pro
Note that the current week’s Weekly Update, earnings updates, position updates and stocks on watch are posted on the website in the Market Update section, which is deleted each week.
Cabot Options Trader Pro Weekly Update October 3: Long positions: XBI, GOOG, M, OXY, PYPL, SBUX. Bearish Positions: SPY
Cabot Options Trader Basic Weekly Update October 3: The month of September was flat out ugly for the market as the S&P 500 fell 9.3%, its worst monthly drop since March 2020 (Covid). And the numbers were similarly negative this last week as the S&P 500 and Dow lost 3%, and the Nasdaq fell another 2.7%.
Cabot Options Trader Alert Basic and Pro September 22: Sell/Adjust Two Positions: Sell your AR November 45 Calls for $0.55 or more and Half of your GOOGL February 120 Calls for $2.50 or more.
Cabot Options Trader Alert Basic and Pro September 19: Covered Call: Buy Cameco (CCJ) Stock and Sell the October 28 Call (exp. 10/21) for a net price of $26.15 or less.
Cabot Options Trader Position Update September 14: Position Update – SBUX and PYPL, and STILL Watching CCJ
Cabot Undervalued Stocks Advisor
Weekly Update October 12: Stocks, of course, continue to tumble. Investors’ plates are overflowing with fears ranging from inflation to trade/military wars to financial collapse to the upcoming midterm elections in the United States. While it can be daunting to separate out how these affect stocks, we use some simple math (by far our favorite kind of math) below in an attempt to isolate what is dragging down share prices. Earnings and interest rates have a powerful influence on stock prices, and our work shows that nearly all of the market’s decline this year is driven by these two components.
Monthly Issue October 5: Many industries are undergoing the first major inventory cycle in a generation, which investors may not be evaluating properly. Also, barring an economic collapse, buying Gates Industrial (GTES) at 8.1x estimated 2023 earnings, Dow (DOW) at 7.9x and Allison Transmission (ALSN) at 5.3x seem like smart opportunistic moves for long-term investors and traders alike.
Cabot Stock of the Week
Weekly Issue October 3: Stocks were basically neutral in the last week, with some signs of life bubbling up beneath the surface. In fact, most of our stocks had good weeks – and a couple of them were very good. Still, it remains highly volatile out there, and the selling isn’t necessarily over. And that makes it a good time to add another contrarian play. This week, that means adding our first (ever?) fund, which takes advantage of the fast growth happening outside U.S. borders – and it’s severely undervalued. It’s a recent recommendation from Cabot Explorer chief analyst Carl Delfeld.
Bi-weekly Update October 6: Stocks struggled back from early losses yesterday after blue chips posted their biggest two-day gains in more than two years.
Bi-weekly Issue September 29: All three major U.S. indexes were up around 2% yesterday as the Bank of England stepped in to stabilize the pound, but the recovery looks fragile as sentiment remains mixed at best in the short term. Explorer stocks drifted lower this past week and we remain defensive looking for asymmetric plays where the upside potential exceeds downside risk.
Cabot Small-Cap Confidential
Monthly Issue October 6: The market has been trying to climb off its knees this week as we’re finally getting some solid evidence that both inflation and the job market are cooling.
Weekly Update September 22: Well, the market got exactly what it expected yesterday when the Fed hiked by 75bps (the odds were over 80% that’s what they’d do). Fed Chair Jerome Powell’s messaging was consistent with what he said back in August in Jackson Hole.
Cabot Dividend Investor
Monthly Issue October 12: In an otherwise miserable year of nonstop inflation, recession, the Fed, and a bear market, an opportunity is emerging for opportunistic investors. Attractive rates on conservative fixed-rate investments have reemerged. There is a chance to lock in rates not seen since the decade before last.
Weekly Update October 5: After an awful September and third quarter, the market roared back earlier this week on bad economic news.
Cabot Early Opportunities
Alert September 23: With the market continuing to have indigestion following the Fed’s 75bps rate hike and higher-for-longer messaging (regarding interest rates), we’re going to trim our position in Toast (TOST) today to reduce the risk of things getting away from us. This sale follows sales of other names last week and early this week, several of which were to lock in partial gains.
Monthly Issue September 21: This month’s issue features a couple of old friends that are shaping up again, plucks one healthy stock off the Watch List and digs into two fresh names that seem to have the wind at their backs.
Alert September 16: With the market looking iffy, the Fed on tap next week and a new Issue slated for Wednesday, I’m going to reduce our exposure a little today by selling Samsara (IOT).
Cabot Profit Booster
Weekly Issue October 4: The month of September was flat-out ugly for the market as the S&P 500 fell 9.3%, its worst monthly drop since March 2020 (Covid). And the numbers were similarly negative this last week as the S&P 500 and Dow lost 3%, and the Nasdaq fell another 2.7%.
Alert September 16: August and September have brought plenty of ups and downs for the stock market, and not surprisingly the Profit Booster also had its ups and downs. One of our trades didn’t work, two are good, and two will expire for full profits. Let’s dive in …
Cabot Micro-Cap Insider
Monthly Issue October 12: Today, I’m recommending a real estate company that is 86% owned by insiders.
Weekly Update October 5: I love Twitter. The social media platform, not the stock. While it’s easy to get lost “doom scrolling” on Twitter, I find it to be an incredibly helpful investment tool. Two terrific charts showed up in my feed this week.
Cabot Income Advisor
Weekly Update October 5: It’s been a furious rally so far this week. It’s only lunchtime on Tuesday. But I’ll take it. September was an abysmal month, in a rotten third quarter, in an awful 2022. Investors can’t contend with persistent high inflation, a hawkish Fed, and a recession. The most recent selloff took just about every stock down with it.
Monthly Issue September 28: Markets go up and down. Economies boom and bust. Investors get scared and they get greedy. But one of the few constants in an ever-changing investment landscape is the need for income. And investor demand for income is growing as the fastest growing segment of the population is 65 and older and retired.
Cabot Turnaround Letter
Alert October 7: Today we are raising our rating on shares of Macy’s (M) from Hold to Buy.
Weekly Update October 7: What to buy when the bear market drags down every new idea? We screen for attractive stocks with low P/E multiples (below 5.5x) and rising estimates, and find Chord Energy (CHRD), Group 1 Automotive (GPI), Jackson Financial (JXN) and Sylvamo Corporation (SLVM). Our second screen is for attractive stocks with high dividend yields, producing KeyCorp (KEY) and Weyerhaeuser (WY), and we suggest investors avoid Altria Group (MO) and 3M Corporation (MMM) whose dividends look vulnerable. Our feature recommendation this month is Dow (DOW), a high quality company with beaten down shares and a 6.3% dividend yield. Check out the unique and valuable Catalyst Report.
This week: Raising our rating on Macy’s (M) from Hold to Buy, with a $20 price target, as investors are pushing the shares down past what is reasonable for this improved company. And, it is time for investors sitting on excess cash to nibble on overly discounted shares. Our annual trip to the shopping mall finds immense discounts but also a lot of unmerchantable goods.
Monthly Issue September 28: What to buy when the bear market drags down new idea? We screen for attractive stocks with low P/E multiples (below 5.5x) and rising estimates, and find Chord Energy (CHRD), Group 1 Automotive (GPI), Jackson Financial (JXN) and Sylvamo Corporation (SLVM). Our second screen is for attractive stocks with high dividend yields, producing KeyCorp (KEY) and Weyerhaeuser (WY), and we suggest investors avoid Altria Group (MO) and 3M Corporation (MMM) whose dividends look vulnerable. Our feature recommendation this month is Dow (DOW), a high quality company with beaten down shares and a 6.3% dividend yield.
Cabot Money Club
Monthly Magazine October: Finding the right time to retire is tough in any market, but today’s volatility, inflation and rising rates make that decision even harder. If you’re considering (or are in) retirement, here’s how to save, how to spend, and, most importantly, how to boost your retirement nest egg.
Monthly Magazine September: remember when most people didn’t give too much thought to health insurance. And if they did, it was in a positive light. For example, my first memory of health insurance was when my sister Pat had her tonsils removed when she was 15. Right after that, my parents bought her a stereo! Of course, I asked why she got a stereo and my brother and I didn’t get anything—it wasn’t even her birthday!
Ask the Experts
Cabot Top Ten Trader
Question: Hi Mike - As Growth Investor (and me) is holding so much cash, I’ve wondered if I should be doing something smarter with my cash as I wait to reinvest it. What’s your perspective? Is it worth moving it to a high-yield savings account? Or money market account? Or treasuries? I don’t have any experience with the latter two options. Thanks for any input you have,
Mike: Thanks for writing. Popular question these days.So we value liquidity so we can quickly put stuff back to work, so we just use money market funds … though, at least at Fidelity (where I personally use it), it actually does yield 2% to 2.5%. But the point is that’s a growth portfolio and we’re trying to make money in growth stuff – if you have “extra” money you want to invest for income, sure, no problem, but we’d prefer just keeping it liquid so you can take advantage of any opportunities, especially if you’re getting 1% to 3% anyway at a money fund – the extra juice from a savings account likely isn’t much anyway.
Quarterly Cabot Analyst Meeting
The recording of the Cabot Prime Members Meeting with the Analysts from January 12, 2022 is now available for you to listen to at your convenience—click here for access. This private call with our analysts is one of your exclusive Cabot Prime Pro member benefits.